Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Condition(s):Gastrointestinal Stromal Tumors; Minimal Residual DiseaseLast Updated:September 21, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Gastrointestinal Stromal Tumors; Minimal Residual DiseaseLast Updated:September 21, 2022Recruiting
Condition(s):Cholangiocarcinoma, IntrahepaticLast Updated:August 18, 2022Recruiting
Condition(s):Crohn DiseaseLast Updated:September 7, 2023Terminated
Condition(s):Prostate Cancer; Biochemical RecurrenceLast Updated:March 12, 2024Recruiting
Condition(s):Recurrent PterygiumLast Updated:July 9, 2020Unknown status
Condition(s):TuberculosisLast Updated:February 2, 2017Completed
Condition(s):Hepatocellular CarcinomaLast Updated:June 4, 2020Completed
Condition(s):Pulsatile TinnitusLast Updated:May 12, 2023Recruiting
Condition(s):Colorectal AdenomaLast Updated:May 21, 2014Unknown status
Condition(s):Recurrent Prostate CancerLast Updated:October 6, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.